300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Mobile
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Facebook
Renewable Energy
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Blockchain
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Zimbabwe
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Nepal
Turkey
Liberia
Mexico
Pakistan
Tajikistan
Sweden
Zambia
Oman
Romania
Puerto Rico
Poland
Colombia
Guernsey
Cameroon
Armenia
China
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mauritius
Mozambique
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Seychelles
Moldova
Botswana
South Africa
Paraguay
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Rwanda
Tanzania
Latvia
United States
Middle East
Indonesia
Dominican Republic
Asia
Bermuda
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Essex Bio-Technology, VC Fund

Essex Bio-Technology

VC Fund

Hong Kong, Hong Kong

Essex Bio-Technology is a VC fund in Hong Kong focused on Health Care and Biotechnology. Essex Bio-Technology Limited (“EssexBio Group” and the “Company”) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001.Essex specializes in biopharmaceutical drug development based on recombinant DNA technology. It is principally engaged in the manufacture and saleof biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Group also engaged in the research and development of bFGF products for new indications, as well as other ophthalmic pharmaceutical projects.A series of genetically engineered bio-pharmaceutical drugs have been successfully developed and three of them were classified as State-level Category I new drugs. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin.

Total investments:
2
Last investment:
Lead investor:
50%

Last updated:

Industries Essex Bio-Technology invests in

Health CareBiotechnologyMedicalTherapeuticsMedical Device

Stages Essex Bio-Technology invests in

SeedSeries B

Countries Essex Bio-Technology invests in

SingaporeUnited States

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 2 (100%)
  • Biotechnology 2 (100%)
  • Medical 1 (50%)
  • Therapeutics 1 (50%)
  • Medical Device 1 (50%)
See all 6 industries →

Stage

  • Seed 1 (50%)
  • Series B 1 (50%)

Country

  • Singapore 1 (50%)
  • United States 1 (50%)

Team

NameTitleInvestmentsLinksEmail
Choon-Peng Ng
Choon-Peng Ng Senior Director (Commercial Strategy and Partnering)
Senior Director (Commercial Strategy and Partnering) Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
X-ZELL is an award-winning medical technology company founded by Y Combinator alumnus, Dr Sebastian Bhakdi. We develop innovative laboratory solutions that enable same-day cancer diagnoses from minimally invasive sample material – we call it next-generation cytology (NGC). $4M / Seed / May 01, 2018
MeiraGTx is committed to the development and commercialization of innovative gene therapy products to transform the lives of patients suffering from acquired and inherited disorders.The company is dedicated to advancing innovative treatments for patients with serious medical conditions. MeiraGTx's research and development efforts primarilyrevolve around gene therapy, a cutting-edge approach that involves modifying or replacing faulty genes to treat or prevent diseases. Led by an experienced management team, we have taken a portfolio approach by licensing, acquiring, and developing technologies that give us depth across both product candidates and indications. Though initially focusing on the eye, salivary gland, and central nervous system, we intend to expand our focus in the future to develop additional gene therapy treatments for patients suffering from a range of serious diseases. $5M / Series B / Mar 16, 2018

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Mobile
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Facebook
Renewable Energy
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Blockchain
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Zimbabwe
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Nepal
Turkey
Liberia
Mexico
Pakistan
Tajikistan
Sweden
Zambia
Oman
Romania
Puerto Rico
Poland
Colombia
Guernsey
Cameroon
Armenia
China
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mauritius
Mozambique
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Seychelles
Moldova
Botswana
South Africa
Paraguay
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Rwanda
Tanzania
Latvia
United States
Middle East
Indonesia
Dominican Republic
Asia
Bermuda
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Essex Bio-Technology invest in?

Essex Bio-Technology invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Essex Bio-Technology?

Public channels for Essex Bio-Technology include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Essex Bio-Technology?

The team at Essex Bio-Technology includes Choon-Peng Ng (Senior Director (Commercial Strategy and Partnering)). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Essex Bio-Technology Essex Bio-Technology Find emails